Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Indaptus Therapeutics Q3 EPS $(0.42) Up From $(0.81) YoY

Indaptus Therapeutics Q3 EPS $(0.42) Up From $(0.81) YoY

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.42) per share. This is a 48.15 percent increase over losses of $(0.81) per share from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.42) per share. This is a 48.15 percent increase over losses of $(0.81) per share from the same period last year.

Meta, Amazon And 3 Stocks To Watch Heading Into Thursday

By Lisa Levin

October 26, 5:31 AM

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

AMZN

Fidelity Files Amended S-1 for Spot Ether ETF With SEC

By Murtuza Merchant

May 21, 8:39 AM

US asset management giant Fidelity has filed an amended S-1 application with the United States Securities and Exchange Commission (SEC) for its spot Ether exchange-traded fund (ETF).

ETH